Skip Navigation
Print This Page
Share this page: More

Human Subjects: Gene Transfer or Experimental Treatment with Synthetic Nucleic Acid Molecules, Potential Pathogens, or Biological Toxins

Studies that involve the use of Recombinant or Synthetic Nulcleic Acid Molecules, potentially Infectious or Pathogenic agents, Biological toxins in human subjects must be reviewed and approved by the Institutional Biosafety Committee (IBC).

Investigators who intend to submit a human pathogen or gene transfer protocol to the Johns Hopkins Institutional Review Board (IRB) should contact the Biosafety Officer for IBC submission details.

>Back to Top

Health, Safety, and Environment News and Announcements


Occupational Health - The 2014–2015 Flu Season Is Winding Down (4/16/2015)

Updated Policy - HSE501 - Bloodborne Pathogen Exposure Control Plan (4/3/2015)

New Guidance - HSE G11: Guidance for Corrective Actions and Progressive Response for Ongoing or Repeat Laboratory Safety Violations (2/3/2015)

NEWS PodcastsRSS

DOT Training- Shipping Ebola Contaminated Waste (11/21/14)

HSE policies have been moved to the Hopkins Policies Online (HPO) website (7/8/14)



© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.